Trupanion, Inc. (NASDAQ:TRUP) Stock Has Average Target Price of $39.20 According to Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been assigned an average recommendation of “Hold” from the six analysts that are covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $39.20.

A number of brokerages have recently commented on TRUP. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research note on Wednesday, July 15th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday, August 24th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday. Finally, Stifel Nicolaus raised their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research report on Thursday, August 20th.

Trupanion Stock Up 1.5%

Shares of TRUP opened at $23.70 on Tuesday. Trupanion has a 52 week low of $21.16 and a 52 week high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The company has a market capitalization of $1.04 billion, a price-to-earnings ratio of 44.72, a PEG ratio of 1.58 and a beta of 1.44. The stock’s 50-day moving average price is $26.92 and its 200-day moving average price is $25.54.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same period last year, the company earned $0.22 earnings per share. Trupanion’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, sell-side analysts predict that Trupanion will post 0.63 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Margaret Tooth sold 978 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the sale, the chief executive officer directly owned 175,401 shares of the company’s stock, valued at $5,095,399.05. This represents a 0.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of the firm’s stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total value of $183,391.11. Following the sale, the chief financial officer owned 4,230 shares in the company, valued at $126,942.30. This trade represents a 59.09% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 13,046 shares of company stock worth $380,162. Company insiders own 5.58% of the company’s stock.

Institutional Trading of Trupanion

A number of institutional investors and hedge funds have recently made changes to their positions in TRUP. Kelleher Financial Advisors purchased a new position in shares of Trupanion during the 2nd quarter valued at approximately $42,000. Parallel Advisors LLC grew its position in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Trupanion during the second quarter worth about $89,000. Fifth Third Bancorp increased its stake in shares of Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock worth $194,000 after purchasing an additional 7,336 shares in the last quarter. Finally, Arizona State Retirement System raised its position in shares of Trupanion by 7.7% during the 2nd quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider’s stock worth $237,000 after purchasing an additional 688 shares during the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical coverage for cats and dogs. Its subscription-based policies are designed to help pet owners manage the cost of eligible veterinary care, including coverage for unexpected illnesses and injuries. Depending on the policy and jurisdiction, coverage may include diagnostic tests, surgeries, hospital stays and prescription medications, subject to applicable terms, exclusions and deductibles.

The company also develops technology intended to simplify the relationship between pet owners, veterinarians and insurers.